This content is machine translated Venous thromboembolism prevention PCSK9 inhibitors: Current evidence, mechanisms and unanswered questions Venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cause of cardiovascular mortality worldwide after myocardial infarction and stroke. Despite continuous...…
View Post 4 min This content is machine translated CV Health Update 2023 Hypercholesterolemia – Strengthen Cardiovascular Prevention At the hybrid event “CV Health Update 2023,” Prof. Isabella Sudano, MD, Senior Physician, Head of Cardiovascular Risk Factors, Department of Cardiology Heart Center University Hospital Zurich, presented the current…
View Post 3 min This content is machine translated Blood pressure and lipid management Effects of effective therapy on cardiovascular health. A major factor in the development of atherosclerotic-related cardiovascular disease is the retention and accumulation of cholesterol-rich lipoproteins in the vessels. Therefore, in addition to adequate blood pressure control, the…
View Post 7 min This content is machine translated 56th Continuing Medical Education Course, Davos “State of the art” in cardiovascular prevention and depression. Cardiovascular diseases remain the leading causes of illness and death in Switzerland as well. In turn, atherosclerosis is the most important cause of these diseases. It begins in adolescence or…
View Post 7 min This content is machine translated Secondary prevention after ischemic stroke Early aspirin treatment is very effective After ischemic stroke of noncardioembolic etiology: early aspirin treatment is extremely effective in preventing recurrence. Atrial fibrillation should be treated with one of the new oral anticoagulants because of the…
View Post 6 min This content is machine translated ACC Congress in Chicago Cholesterol management under the microscope Two studies in the field of lipid therapy caused a stir at the ACC Congress in Chicago. HOPE-3 presented a pragmatic approach to primary prevention for discussion. The study showed…
View Post 6 min This content is machine translated Statin therapy Lipid lowering in old age – does it make sense? The benefits of statin therapy in secondary prevention should not be denied in principle to older patients at risk. Currently, statins have no value in primary prophylaxis in old age.…
